SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-000473
Filing Date
2021-01-28
Accepted
2021-01-28 07:55:40
Documents
12
Period of Report
2021-01-28
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20210128x8k.htm   iXBRL 8-K 41249
  Complete submission text file 0001558370-21-000473.txt   158886

Data Files

Seq Description Document Type Size
2 EX-101.SCH axsm-20210128.xsd EX-101.SCH 3250
3 EX-101.LAB axsm-20210128_lab.xml EX-101.LAB 15501
4 EX-101.PRE axsm-20210128_pre.xml EX-101.PRE 10536
5 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20210128x8k_htm.xml XML 4687
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 21562063
SIC: 2834 Pharmaceutical Preparations